Quantum Computing (QUBT) Dropped, So What Is Behind The Fresh Attention?

Quantum Computing (QUBT) just landed its first commercial biopharma project, teaming up with INmune Bio to apply its Dirac-3S quantum optimization machine to Alzheimer’s and inflammation-focused clinical datasets.

For Quantum Computing, this first commercial biopharma engagement comes at a time of weak price performance, with the share price down 24.64% over 30 days and 42.23% year to date, and one year total shareholder return falling 65.30% even after a very large three year total shareholder return. Momentum has clearly cooled in the short term despite fresh contract wins and recent conference appearances.

Spot 24 quantum computing stocks, which, like Quantum Computing, is trying to turn cutting edge physics into real commercial contracts in areas such as biotech, defense, and advanced sensing.

Quantum Computing now has real biopharma work and very weak recent returns. The key issue is simple: Is this emerging platform still priced like a story, or already being treated like a bargain on today’s numbers?

Most Popular Narrative: 65% Undervalued

Analysts following Quantum Computing anchor on a fair value of $18.33 per share, while the last close sits at $6.36. This sets up a wide gap that the narrative tries to explain through aggressive growth and thin future margins under a single valuation framework.

The move from prototype systems to planned volume manufacturing by the end of the decade, supported by over $1.5 billion of newly raised capital and a low liability balance, allows QCi to invest aggressively in automation, yield improvement and design reuse. These efforts should help reduce unit costs and support sustained improvement in gross margin and earnings power.

See why 73 investors see Quantum Computing as 65% undervalued.

The widely followed thesis prices Quantum Computing using an $18.33 fair value. This is built on a discount rate of 8.51%, very large projected revenue expansion and a profit margin assumption of roughly 0.73%. At $6.36, the market is assigning a much lower dollar value to that same earnings pathway, even before questioning whether a future P/E multiple in the several thousand times range feels realistic for a US Tech stock.

Analysts in that framework bake in roughly 283% annual revenue growth through the model period and expect earnings to move from a current loss position of $39.7 million to a modest profit of $1.8 million by 2029. That path then backs into a future P/E multiple of about 3,624x to reconcile the forecast earnings with the $18.33 fair value. This is a far higher ratio than the 41.2x level cited for the broader US Tech industry in the same narrative.

There is also a spread of opinion inside that consensus. Targets range from $10 at the low end to $30 at the top. Even the bullish case in the narrative acknowledges a wide band of possible outcomes around revenue of $243.4 million, small positive earnings and heavy reliance on a very rich multiple to justify today’s fair value estimate.

Result: Fair Value of $18.33 (UNDERVALUED)

Still, the entire story can be knocked off course if Quantum Computing fails to turn small, concentrated contracts into broader revenue, or if rising operating costs keep outpacing sales.

Find out about the key risks to this Quantum Computing narrative.

Next Steps

If this mix of weak recent returns and bullish fair value estimates for Quantum Computing feels conflicted, treat it as a prompt to inspect the details yourself. You can start by reviewing the upside case that analysts see in the 1 key reward.

Looking for more Quantum Computing investment ideas?

If Quantum Computing has your attention, do not stop here. Broaden your watchlist so you are not relying on a single story to carry your portfolio.

• Target future upside by scanning companies that combine solid fundamentals with prices that look out of sync with their quality through the 33 high quality undervalued stocks.
• Strengthen your income stream by checking out companies that offer higher yields and focus on keeping payouts resilient using the 8 dividend fortresses.
• Dial down portfolio risk by filtering for businesses with sturdy finances, low leverage and dependable balance sheets through the list of solid balance sheet and fundamentals (25 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com